We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Launched in October 2016, Big Drop Brewing is a world-leading alcohol-free craft brewer. The company brews beer naturally by using specialist brewing methods to ensure the alcohol never exceeds 0.5%. The beer is not only Alcohol-Free, but is also gluten-free and many are low in sugar.  Their award-winning lager is vegan-friendly. The company does not have a brewery of its own but partners with reputable breweries around the world, who share their brewing values to produce the beer. Big Drop Brewing has secured private funding already and meaningful distribution in the UK and 12 overseas markets. They have also secured off-trade listings in Tesco, Morrisons and Ocado. Half of the investment will be used for Sales & Marketing, 30% for new branding launch and related marketing, 10% for production costs and the remaining 10% for product development.

Pitch Rated

70%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £617,566
Windsor & Eton Brewery (WAEB) is an award-winning Royal Warrant holding brewery. WAEB brews over 1.4 million pints each year and is on a mission to make beer Windsor's top attraction. WAEB has won over 70 national, international, and regional beer awards. It claims to be a supplier of exclusive bottled beers to the House of Commons, London’s Shakespeare’s Globe, and over 200 pubs, bars, and hotels. The company made over £600,000 of direct sales to consumers through its brewery tap, shop, and home deliveries in 2020. WAEB argues that it is running five successful bars in and near Windsor, serving nearly 7.6 million visitors per year. WAEB created the Windsor beer festival and is a member of the Worshipful Company of Brewers. They intend to use the investment to grow its estate from its existing five venues to twenty by 2026, start with a major new bar in the heart of Windsor, and buy a canning line on-site to ensure fresher beers for its customers.
days to go: Expired investment: £625,931
Run3D is a biotechnology company that has developed a 3D gait analysis system with the aim to help people identify injuries, deliver better performance, and make better running decisions. 3D gait analysis involves using infrared cameras to track positions of small reflective markers attached to a person in motion, capturing measurable data to help quantify a person's risk of injury, biomechanical efficiency, performance, footwear, and recommend proper diagnosis where necessary. The company plans to use the investment to grow its business.
days to go: Expired investment: Withheld
Swoopos is a mobile point of sale system, which brings together innovative software and hardware, cloud reporting and data analytics, mobile and ecommerce ordering and beacon marketing technology for retail, hospitality and stadiums.  Swoops have already built long term relationships with leading brands and are now looking to expand throughout the UK and beyond.
days to go: Expired investment: £64,480
White Peak Distillery (WPD) is a whisky distillery that aims to change the way whisky is made and create authentic flavours. It has so far invested £1.4 million in tried and tested plant equipment producing 400,000 bottles of maturing whisky. The company aims to become a contender in the $60 billion global premium whisky market. WPD has received 'Gold Awards' from The Wizards of Whisky World Whisky Awards. It has come out with programs to monetise its maturing whisky including its Cask Sales program, Temperance Club membership and its Prologue 2.1 release 2-year aged single malt spirit, that has been received with positive feedback. WPD has also been awarded visitor business in The Peak District, which receives 13 million+ visitors per annum, boosting its Direct-to-Consumer (D2C) model. It will use the investment to grow its business across different verticals.

Pitch Rated

82%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £1,301,320
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph